Haupt Pharma Acquires Pfizer's Plant In Italy

Haupt Pharma AG, one of the world's largest pharmaceutical contract manufacturers and developers, announced recently that it has completed the purchase of a Pfizer production site in Latina, Italy. With this asset deal, Haupt Pharma gets access to a plant focused on the production of antibiotics – especially beta-lactams like penicillin and cephalosporin – and is now able to provide its customers with a variety of special products including hormones, cytotoxics and beta-lactams. In addition, the transaction enables Haupt Pharma to expand its Italian business and improve its market position in the traditional export markets of Italy. At the same time, the company continues to supply Pfizer on a global basis.

With the deal, Haupt Pharma's business volume grows by 30 percent. "Through the acquisition of the Latina plant with its state-of-the-art facilities and highly qualified staff, we are well positioned to significantly expand our international market position. In Italy, we are expecting a considerable increase in demand for generic medicaments within the next ten years. Moreover, our new beta-lactams competence centre in Latina enables us to complete our product portfolio and to improve our competitive advantages", says Hans-Christian Semmler, Chairman of Haupt Pharma.

The Latina plant currently employs more than 450 people; all the em-ployees will be transferred. The site which produces injectables and solid drugs for human and veterinarian use is equipped with up to date facilities that, together with a world-class quality management system, not only meet but also exceed "Good Manufacturing Practice" guidelines for the quality con-trol testing of pharmaceutical products.

About Haupt Pharma AG
Haupt Pharma is one of the world's largest pharmaceutical contract manufacturers and developers. The company was founded in 1937 in Berlin, which is still the headquarters of the holding today. The group's services are also provided from the locations of Brackenheim, Gronau, Münster, Regensburg, Wolfratshausen, Livron (France) and Toride (Japan). In addition, Haupt Pharma cooperates with Siegfried Generics in Valletta (Malta). Since the year 2000, Haupt Pharma AG is the holding of the group. For 2009, the company expects – after the acquisition of Pfizer's site in Latina – a worldwide turnover of about €250 million with a workforce of about 2,000. For more information visit www.haupt-pharma.de.

AboutPfizer Inc.
Pfizer Inc., founded in 1849, is dedicated to better health and greater access to health care for people and their valued animals. Every day, approximately 81,900 colleagues in more than 150 countries work to discover, develop, manufacture and deliver quality, safe and effective prescription medicines to patients.

For more information visit www.pfizer.com.

SOURCE: Haupt Pharma AG